Bioavailability of a pediatric amlodipine suspension

Dorothy A. Lyszkiewicz, Zina Levichek, Eran Kozer, Yaron Yagev, Myla Moretti, Marjie Hard, Gideon Koren*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Currently, a suspension of crushed tablets of amlodidpine is widely used in children with hypertension without knowledge of its bioavailability. A comparative bioavailability study of a tablet and suspension formulation of amlodipine was completed in 20 healthy adult volunteers. Bioequivalence of the suspension was not different from the tablets. These results support the use of the suspension in children who cannot take the tablet.

Original languageEnglish
Pages (from-to)675-678
Number of pages4
JournalPediatric Nephrology
Volume18
Issue number7
DOIs
StatePublished - 1 Jul 2003
Externally publishedYes

Keywords

  • Amlodipine
  • Bioavailability
  • Bioequivalence
  • Pediatric formulation
  • Stability
  • Suspension

Fingerprint

Dive into the research topics of 'Bioavailability of a pediatric amlodipine suspension'. Together they form a unique fingerprint.

Cite this